Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.25 | 1e-13 |
mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.21 | 2e-11 |
mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.21 | 1e-10 |
mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.18 | 1e-07 |
mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.25 | 3e-07 |
mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.18 | 3e-07 |
mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | -0.17 | 5e-06 |
mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.24 | 6e-06 |
mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.24 | 7e-06 |
mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.16 | 9e-06 |